메뉴 건너뛰기




Volumn 54, Issue 12, 2013, Pages 2720-2727

Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes

Author keywords

Host genes; Hypermethylation; MicroRNAs; Myelodysplastic syndrome; Myeloid maturation

Indexed keywords

MICRORNA; MIRNA 103 1; MIRNA 140; MIRNA 342; MIRNA 378; MIRNA 483; MIRNA 632; MIRNA 636; MIRNA150; UNCLASSIFIED DRUG;

EID: 84885010257     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.790542     Document Type: Article
Times cited : (11)

References (40)
  • 2
    • 79959851207 scopus 로고    scopus 로고
    • Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: High number of uncaptured cases by cancer registries
    • Cogle CR, Craig BM, Rollison DE, et al . Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries . Blood 2011 ; 117 : 7121-7125 .
    • (2011) Blood , vol.117 , pp. 7121-7125
    • Cogle, C.R.1    Craig, B.M.2    Rollison, D.E.3
  • 3
    • 79952362122 scopus 로고    scopus 로고
    • Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes
    • Starczynowski DT, Vercauteren S, Sung S, et al . Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes . Leuk Res 2011; 35: 444-447.
    • (2011) Leuk Res , vol.35 , pp. 444-447
    • Starczynowski, D.T.1    Vercauteren, S.2    Sung, S.3
  • 4
    • 54049105351 scopus 로고    scopus 로고
    • High-resolution whole genome tiling path array CGH analysis of CD34-cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
    • Starczynowski DT, Vercauteren S, Telenius A, et al . High-resolution whole genome tiling path array CGH analysis of CD34-cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival . Blood 2008 ; 112 : 3412-3424 .
    • (2008) Blood , vol.112 , pp. 3412-3424
    • Starczynowski, D.T.1    Vercauteren, S.2    Telenius, A.3
  • 5
    • 77954468513 scopus 로고    scopus 로고
    • Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities
    • Vercauteren S M, S ung S, S tarczynowski D T, et a l. A rray comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities . Am J Clin Pathol 2010 ; 134 : 119-126 .
    • (2010) Am J Clin Pathol , vol.134 , pp. 119-126
    • Vercauteren, S.M.1    Sung, S.2    Starczynowski, D.T.3
  • 6
    • 70350720044 scopus 로고    scopus 로고
    • MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
    • Figueroa ME, Skrabanek L, Li Y, et al . MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation . Blood 2009 ; 114 : 3448-3458 .
    • (2009) Blood , vol.114 , pp. 3448-3458
    • Figueroa, M.E.1    Skrabanek, L.2    Li, Y.3
  • 7
    • 83455234787 scopus 로고    scopus 로고
    • Clinical signifi cance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    • Malcovati L, Papaemmanuil E, Bowen DT, et al . Clinical signifi cance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/ myeloproliferative neoplasms . Blood 2011; 118: 6239-6246 .
    • (2011) Blood , vol.118 , pp. 6239-6246
    • Malcovati, L.1    Papaemmanuil, E.2    Bowen, D.T.3
  • 8
    • 80054010617 scopus 로고    scopus 로고
    • Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts
    • Papaemmanuil E, Cazzola M, Boultwood J, et al . Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts . N Engl J Med 2011 ; 365 : 1384-1395 .
    • (2011) N Engl J Med , vol.365 , pp. 1384-1395
    • Papaemmanuil, E.1    Cazzola, M.2    Boultwood, J.3
  • 9
    • 84855841586 scopus 로고    scopus 로고
    • SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
    • Patnaik MM, Lasho TL, Hodnefi eld JM, et al . SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value . Blood 2012 ; 119 : 569-572 .
    • (2012) Blood , vol.119 , pp. 569-572
    • Patnaik, M.M.1    Lasho, T.L.2    Hodnefield, J.M.3
  • 10
    • 80053900941 scopus 로고    scopus 로고
    • Frequent pathway mutations of splicing machinery in myelodysplasia
    • Yoshida K, Sanada M, Shiraishi Y, et al . Frequent pathway mutations of splicing machinery in myelodysplasia . Nature 2011; 478: 64-69.
    • (2011) Nature , vol.478 , pp. 64-69
    • Yoshida, K.1    Sanada, M.2    Shiraishi, Y.3
  • 11
    • 59149102237 scopus 로고    scopus 로고
    • Target site eff ects in the RNA interference and microRNA pathways
    • Obernosterer G, Tafer H, Martinez J . Target site eff ects in the RNA interference and microRNA pathways . Biochem Soc Trans 2008 ; 36 : 1216-1219 .
    • (2008) Biochem Soc Trans , vol.36 , pp. 1216-1219
    • Obernosterer, G.1    Tafer, H.2    Martinez, J.3
  • 12
    • 47149109822 scopus 로고    scopus 로고
    • MicroRNAs in normal and malignant hematopoiesis
    • Garzon R, C roce C M. M icroRNAs in normal and malignant hematopoiesis . Curr Opin Hematol 2008 ; 15 : 352-358 .
    • (2008) Curr Opin Hematol , vol.15 , pp. 352-358
    • Garzon, R.1    Croce, C.M.2
  • 13
    • 70249129354 scopus 로고    scopus 로고
    • MicroRNAs in normal and malignant myelopoiesis
    • Pelosi E, Labbaye C, Testa U . MicroRNAs in normal and malignant myelopoiesis . Leuk Res 2009; 33: 1584-1593.
    • (2009) Leuk Res , vol.33 , pp. 1584-1593
    • Pelosi, E.1    Labbaye, C.2    Testa, U.3
  • 14
    • 80051475292 scopus 로고    scopus 로고
    • Diagnostic microRNAs in myelodysplastic syndrome
    • Erdogan B, Facey C, Qualtieri J, et al . Diagnostic microRNAs in myelodysplastic syndrome . Exp Hematol 2011 ; 39 : 915-926 .e2.
    • (2011) Exp Hematol , vol.39
    • Erdogan, B.1    Facey, C.2    Qualtieri, J.3
  • 15
    • 79955945973 scopus 로고    scopus 로고
    • Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
    • Tiu RV, Gondek LP, O' Keefe CL, et al . Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies . Blood 2011 ; 117 : 4552-4560 .
    • (2011) Blood , vol.117 , pp. 4552-4560
    • Tiu, R.V.1    Gondek, L.P.2    O'Keefe, C.L.3
  • 16
    • 6344281172 scopus 로고    scopus 로고
    • Identifi cation of mammalian microRNA host genes and transcription units
    • Rodriguez A, Griffi ths-Jones S, A shurst J L, et a l. I dentifi cation of mammalian microRNA host genes and transcription units . Genome Res 2004; 14: 1902-1910.
    • (2004) Genome Res , vol.14 , pp. 1902-1910
    • Rodriguez, A.1    Griffiths-Jones, S.2    Ashurst, J.L.3
  • 17
    • 13944260434 scopus 로고    scopus 로고
    • Microarray profi ling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes
    • Baskerville S, Bartel DP . Microarray profi ling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes . RNA 2005 ; 11 : 241-247 .
    • (2005) RNA , vol.11 , pp. 241-247
    • Baskerville, S.1    Bartel, D.P.2
  • 18
    • 67049104896 scopus 로고    scopus 로고
    • An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
    • Ronchetti D, L ionetti M, M osca L, et a l. A n integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma . BMC Med Genomics 2008 ; 1 : 37 .
    • (2008) BMC Med Genomics , vol.1 , pp. 37
    • Ronchetti, D.1    Lionetti, M.2    Mosca, L.3
  • 19
    • 0001679798 scopus 로고
    • Induction of diff erentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
    • Breitman TR, Selonick SE, Collins SJ . Induction of diff erentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid . Proc Natl Acad Sci USA 1980 ; 77 : 2936-2940 .
    • (1980) Proc Natl Acad Sci USA , vol.77 , pp. 2936-2940
    • Breitman, T.R.1    Selonick, S.E.2    Collins, S.J.3
  • 20
    • 59149089005 scopus 로고    scopus 로고
    • Role of microRNAs in myeloid diff erentiation
    • Fatica A, Rosa A, Ballarino M, et al . Role of microRNAs in myeloid diff erentiation . Biochem Soc Trans 2008 ; 36 : 1201-1205 .
    • (2008) Biochem Soc Trans , vol.36 , pp. 1201-1205
    • Fatica, A.1    Rosa, A.2    Ballarino, M.3
  • 21
    • 70349249936 scopus 로고    scopus 로고
    • Microarray-based classifi ers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
    • Mills K I, K ohlmann A, W illiams P M, et a l. M icroarray-based classifi ers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome . Blood 2009 ; 114 : 1063-1072 .
    • (2009) Blood , vol.114 , pp. 1063-1072
    • Mills, K.I.1    Kohlmann, A.2    Williams, P.M.3
  • 22
    • 21044439177 scopus 로고    scopus 로고
    • Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
    • Kaminskas E, Farrell A, Abraham S, et al . Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes . Clin Cancer Res 2005; 11: 3604-3608.
    • (2005) Clin Cancer Res , vol.11 , pp. 3604-3608
    • Kaminskas, E.1    Farrell, A.2    Abraham, S.3
  • 23
    • 33646071894 scopus 로고    scopus 로고
    • Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study
    • Kantarjian H, Issa JP, Rosenfeld CS, et al . Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study . Cancer 2006 ; 106 : 1794-1803 .
    • (2006) Cancer , vol.106 , pp. 1794-1803
    • Kantarjian, H.1    Issa, J.P.2    Rosenfeld, C.S.3
  • 24
    • 33947281469 scopus 로고    scopus 로고
    • Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience
    • Kantarjian HM, O' Brien S, Huang X, et al . Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience . Cancer 2007 ; 109 : 1133-1137 .
    • (2007) Cancer , vol.109 , pp. 1133-1137
    • Kantarjian, H.M.1    O'Brien, S.2    Huang, X.3
  • 25
    • 33748474416 scopus 로고    scopus 로고
    • Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
    • Silverman L R, M cKenzie D R, P eterson B L, et a l. F urther analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B . J Clin Oncol 2006 ; 24 : 3895-3903 .
    • (2006) J Clin Oncol , vol.24 , pp. 3895-3903
    • Silverman, L.R.1    McKenzie, D.R.2    Peterson, B.L.3
  • 26
    • 84860767817 scopus 로고    scopus 로고
    • SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications
    • Damm F, Th ol F, Kosmider O, et al . SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications . Leukemia 2012; 26: 1137-1140.
    • (2012) Leukemia , vol.26 , pp. 1137-1140
    • Damm, F.1    Thol, F.2    Kosmider, O.3
  • 27
    • 84887246728 scopus 로고    scopus 로고
    • The role of haploinsuffi ciency of RPS14 and p53 activation in the molecular pathogenesis of the 5q-syndrome
    • Boultwood J . The role of haploinsuffi ciency of RPS14 and p53 activation in the molecular pathogenesis of the 5q-syndrome . Pediatr Rep 2011; 3(Suppl. 2): e10.
    • (2011) Pediatr Rep , vol.3 , Issue.SUPPL. 2
    • Boultwood, J.1
  • 28
    • 70349643737 scopus 로고    scopus 로고
    • Low RPS14 expression is common in myelodysplastic syndromes without 5q-aberration and defi nes a subgroup of patients with prolonged survival
    • Czibere A, Bruns I, Junge B, et al . Low RPS14 expression is common in myelodysplastic syndromes without 5q-aberration and defi nes a subgroup of patients with prolonged survival . Haematologica 2009 ; 94 : 1453-1455 .
    • (2009) Haematologica , vol.94 , pp. 1453-1455
    • Czibere, A.1    Bruns, I.2    Junge, B.3
  • 29
    • 38349088899 scopus 로고    scopus 로고
    • Identifi cation of RPS14 as a 5qsyndrome gene by RNA interference screen
    • Ebert BL, Pretz J, Bosco J, et al . Identifi cation of RPS14 as a 5qsyndrome gene by RNA interference screen . Nature 2008 ; 451 : 335-339 .
    • (2008) Nature , vol.451 , pp. 335-339
    • Ebert, B.L.1    Pretz, J.2    Bosco, J.3
  • 30
    • 44649092154 scopus 로고    scopus 로고
    • Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genes
    • Pellagatti A, H ellstrom-Lindberg E, G iagounidis A, et a l. Haploinsuffi ciency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genes . Br J Haematol 2008 ; 142 : 57-64 .
    • (2008) Br J Haematol , vol.142 , pp. 57-64
    • Pellagatti, A.1    Hellstrom-Lindberg, E.2    Giagounidis, A.3
  • 31
    • 1642371165 scopus 로고    scopus 로고
    • Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells
    • Zhang C C, L odish H F. I nsulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells . Blood 2004 ; 103 : 2513-2521 .
    • (2004) Blood , vol.103 , pp. 2513-2521
    • Zhang, C.C.1    Lodish, H.F.2
  • 32
    • 46649097230 scopus 로고    scopus 로고
    • Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer
    • Murrell A, I to Y, V erde G, et a l. D istinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer . PloS One 2008 ; 3 : e1849 .
    • (2008) PloS One , vol.3
    • Murrell, A.1    Ito, Y.2    Verde, G.3
  • 33
    • 0037396541 scopus 로고    scopus 로고
    • Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders
    • Bock O, S chlue J, K reipe H . R educed expression of H19 in bone marrow cells from chronic myeloproliferative disorders . Leukemia 2003 ; 17 : 815-816 .
    • (2003) Leukemia , vol.17 , pp. 815-816
    • Bock, O.1    Schlue, J.2    Kreipe, H.3
  • 34
    • 0036215814 scopus 로고    scopus 로고
    • Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells
    • Hofmann WK, Takeuchi S, Frantzen MA, et al . Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells . Exp Hematol 2002 ; 30 : 318-323 .
    • (2002) Exp Hematol , vol.30 , pp. 318-323
    • Hofmann, W.K.1    Takeuchi, S.2    Frantzen, M.A.3
  • 35
    • 0034329247 scopus 로고    scopus 로고
    • Imprinting of insulinlike growth factor 2 is modulated during hematopoiesis
    • Morison IM, Eccles MR, Reeve AE . Imprinting of insulinlike growth factor 2 is modulated during hematopoiesis . Blood 2000 ; 96 : 3023-3028 .
    • (2000) Blood , vol.96 , pp. 3023-3028
    • Morison, I.M.1    Eccles, M.R.2    Reeve, A.E.3
  • 36
    • 22344452178 scopus 로고    scopus 로고
    • Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern
    • Tessema M, Langer F, Bock O, et al . Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol 2005; 26: 499-507.
    • (2005) Int J Oncol , vol.26 , pp. 499-507
    • Tessema, M.1    Langer, F.2    Bock, O.3
  • 37
    • 79957926724 scopus 로고    scopus 로고
    • WWP2 is an E3 ubiquitin ligase for PTEN
    • Maddika S, Kavela S, Rani N, et al . WWP2 is an E3 ubiquitin ligase for PTEN . Nat Cell Biol 2011 ; 13 : 728-733 .
    • (2011) Nat Cell Biol , vol.13 , pp. 728-733
    • Maddika, S.1    Kavela, S.2    Rani, N.3
  • 38
    • 79957865731 scopus 로고    scopus 로고
    • Biochemical analysis of the human ENA/VASP-family proteins, MENA, VASP and EVL, in homologous recombination
    • Takaku M, U eno H, K urumizaka H . B iochemical analysis of the human ENA/VASP-family proteins, MENA, VASP and EVL, in homologous recombination. J Biochem 2011; 149: 721-729.
    • (2011) J Biochem , vol.149 , pp. 721-729
    • Takaku, M.1    Ueno, H.2    Kurumizaka, H.3
  • 39
    • 77953807425 scopus 로고    scopus 로고
    • Alterations in the mitochondrial regulatory pathways constituted by the nuclear cofactors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes
    • Zorzano A, Hernandez-Alvarez MI, Palacin M, et al . Alterations in the mitochondrial regulatory pathways constituted by the nuclear cofactors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes . Biochim Biophys Acta 2010 ; 1797 : 1028-1033 .
    • (2010) Biochim Biophys Acta , vol.1797 , pp. 1028-1033
    • Zorzano, A.1    Hernandez-Alvarez, M.I.2    Palacin, M.3
  • 40
    • 84872978640 scopus 로고    scopus 로고
    • MicroRNAs in myelodysplastic syndromes: How much do we know and not know
    • Chen C . microRNAs in myelodysplastic syndromes: how much do we know and not know Leuk Res 2013 ; 37 : 241-242 .
    • (2013) Leuk Res , vol.37 , pp. 241-242
    • Chen, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.